Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular InflammationJulian Friebel, Ursula Rauch, Eileen Moritz et al.|Cells|2021Cited by 29
Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial FibrillationJulian Friebel, Ursula Rauch, Marco Witkowski et al.|Cells|2022Cited by 16
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial FibrillationLeon Blöbaum, Julian Friebel, Marco Witkowski et al.|Biomedicines|2023Cited by 15